{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Thompson GR"],"funding":["NIAID NIH HHS","NCI NIH HHS"],"pagination":["e364-e374"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9450022"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["21(12)"],"pubmed_abstract":["The global burden of the endemic mycoses (blastomycosis, coccidioidomycosis, emergomycosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and talaromycosis) continues to rise yearly and these infectious diseases remain a leading cause of patient morbidity and mortality worldwide. Management of the associated pathogens requires a thorough understanding of the epidemiology, risk factors, diagnostic methods and performance characteristics in different patient populations, and treatment options unique to each infection. Guidance on the management of these infections has the potential to improve prognosis. The recommendations outlined in this Review are part of the \"One World, One Guideline\" initiative of the European Confederation of Medical Mycology. Experts from 23 countries contri"],"journal":["The Lancet. Infectious diseases"],"pubmed_title":["Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology."],"pmcid":["PMC9450022"],"funding_grant_id":["R21 AI162367","R01 AI063503","P30 CA008748","R21 AI159397","R01 AI143409","R37 AI093808","P30 AI064518","R01 AI139632"],"pubmed_authors":["Thompson GR","Spec A","Gangneux JP","Alastruey-Izquierdo A","Chamani-Tabriz L","Klimko N","Lopes Bezerra L","Barker BM","Jouvion G","Lee Lee L","Ayanlowo O","Cornely OA","Chindamporn A","Hedayati MT","Krause R","Kenyon C","Hohl TM","Hagen F","Buitrago MJ","Queiroz-Telles F","Ampel NM","Le T","Verweij PE","Andes DR","Rath PM","Kong DCM","Schwartz IS","Chayakulkeeree M","Govender NP","Miceli MH","Chan JFW","Baddley JW","Armstrong-James D","Kauffman CA","Cunwei C","Pasqualotto AC","Kibbler CC","Meintjes G","Variava E"],"additional_accession":[]},"is_claimable":false,"name":"Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology.","description":"The global burden of the endemic mycoses (blastomycosis, coccidioidomycosis, emergomycosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and talaromycosis) continues to rise yearly and these infectious diseases remain a leading cause of patient morbidity and mortality worldwide. Management of the associated pathogens requires a thorough understanding of the epidemiology, risk factors, diagnostic methods and performance characteristics in different patient populations, and treatment options unique to each infection. Guidance on the management of these infections has the potential to improve prognosis. The recommendations outlined in this Review are part of the \"One World, One Guideline\" initiative of the European Confederation of Medical Mycology. Experts from 23 countries contri","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Dec","modification":"2025-04-18T18:25:16.658Z","creation":"2025-04-07T06:05:00.957Z"},"accession":"S-EPMC9450022","cross_references":{"pubmed":["34364529"],"doi":["10.1016/S1473-3099(21)00191-2","10.1016/s1473-3099(21)00191-2"]}}